ABOUT PRODUCTS PIPELINE IMPACT INVESTORS CAREERS CONTACT US NEWS FROM EAGLE FIND OUT WHAT’S NEW AT EAGLE TOP STORIES Eagle Pharmaceuticals Wins Vasopressin Patent Trial Worldwide Licensing Agreement for CAL02 a Phase 2b/3, Novel First-in-Class Antitoxin Agent Licensing Agreement for U.S. Commercial Rights to Landiolol, a Beta-1 Adrenergic Blocker Read the latest from Eagle Pharmaceuticals PRESS RELEASES ABOUT US BRINGING TREATMENT POTENTIAL TO LIFE We discover and develop new formulations to make medicines more convenient and faster to use. Simply put, we work hard to unlock the potential in proven medicines to benefit more patients and healthcare providers. SEE WHY WE DO IT OUR PRODUCTS BEGIN WITH SOMETHING BRILLIANT Our products are the result of expertise and unrelenting effort. We help improve the experience of injectable therapies for patients and physicians through reformulation and delivery innovation. EXPLORE OUR PORTFOLIO PIPELINE OUR FUTURE We are reformulating proven medicines in oncology, critical care, and orphan diseases to give them new life for those who urgently need them. SEE WHAT’S IN THE WORKS INVESTORS THE SKY IS THE LIMIT Our strategic focus on maximizing the potential of proven medicines is designed to optimize our value for patients, healthcare providers and our investors. The bottom line is that we believe our growing portfolio has the power to benefit everyone. HOW WE’RE CREATING VALUE PRIVACY POLICY TERMS OF USE SITEMAP CONTACT US COOKIE SETTINGS © 2021 Eagle Pharmaceuticals, Inc. All rights reserved. Woodcliff Lake, NJ 07677 We have updated our Privacy and Cookie Policies. We have updated our Privacy and Cookie Policies to provide additional information, including new information for California residents and updated information and choices in connection with how we and our partners collect information via cookies. Please read our updated privacy and cookie policies here. You can adjust cookie settings for the website here. By clicking Accept, you agree to our updated privacy and cookie policies.ACCEPT